explore -WSS

explore

author：fashion 2025-09-06 02:12:52 - browse：1

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： How to fix the rural physician shortage in the U.S.

WSS

Brain MRIs reveal impact of 'toxic stress' on Black children

In search for therapies for solid tumors, companies turn to claudin

Why getting cancer drugs just got harder for rural patients

Brain MRIs reveal impact of 'toxic stress' on Black children

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

knowledge

explore

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

FogPharma raises $145 million in rare Series E round

Wildfire smoke exposes gaps in outdoor worker protections

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

How to save PrEP access — and even expand it

Can gargling with Listerine treat gonorrhea of the mouth?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Clinical trials giant ICON acquires HumanFirst

Medicare details structure of new drug price negotiation program

PBM executives asked to testify by House panel

explore

Sepsis can kill a child within hours. Here's how hospitals are fighting back

RaDonda Vaught to speak at CommonSpirit event on patient safety

Congress gives doctors Medicare pay bump

Brain MRIs reveal impact of 'toxic stress' on Black children

Biotech companies concerned about China biosecurity crackdown

Sepsis can kill a child within hours. Here's how hospitals are fighting back

knowledge

focus

explore

focus